Was he ramping HER-Vaxx which wasn't even close to completion of Ph2 clinical trial when the MC was at $2B+ and then still ramping it at an ATH of $3.5B??? Sound like a baseless ramper I know who said RAC's MC will be $800M from just starting Ph1 clinical trial......"pot calling the kettle black" anyone.
IMU Price at posting:
2.6¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)